Author

Mahdi Akbarpour

German Cancer Research CenterORCID 0000-0002-4369-3199Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Amir AbdollahiiD· 2 shared Andrea MairaniiD· 2 shared Ivana ĐokićiD· 2 shared Jürgen DebusiD· 2 shared Mahmoud MoustafaiD· 2 shared Thomas TessonnieriD· 2 shared Celine KarleiD· 1 shared Christian SchömersiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Amir AbdollahiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exploring High LET Oxygen-Ion FLASH Radiation for Targeting Pancreatic Cancer in Vitro and In Vivo

Celine Karle, Domenico Ivan Filosa, Mahdi Akbarpour, Nora Schuhmacher, Stephan Brons, R. Cee, Christian Schömers, Stefan Scheloske, Kristoffer Petersson, Thomas Haberer, Amir Abdollahi, Jürgen Debus, Thomas Tessonnier, Mahmoud Moustafa, Andrea Mairani, Ivana Đokić

This study evaluates oxygen-ion FLASH radiation for in vitro and in vivo pancreatic cancer treatment, showing comparable tumor cell killing to standard dose rates.

Physics and Imaging in Radiation Oncology · Jul 1, 2025Peer-reviewedCancer Biology

Ultra-High Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control

Ivana Đokić, Mahmoud Moustafa, Thomas Tessonnier, Sarah Meister, Federica Ciamarone, Mahdi Akbarpour, Damir Krunic, T. Haberer, Jürgen Debus, Andrea Mairani, Amir Abdollahi

This study compares ultra-high-dose rate helium ion radiotherapy (FLASH) with standard dose rate (SDR) in mice, showing FLASH reduces brain injury and neuroinflammation while maintaining tumor control.

Molecular Cancer Therapeutics · Dec 31, 2024Peer-reviewedCell Biology